← Leaderboards
Anirban Maitra
Johns Hopkins University
$50,247,714
Attributed
$75,790,993
Total exposure
25
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$93,074,748 · 27
By mechanism
U01$46,546,766 · 4
P50$12,888,901 · 4
R01$12,209,240 · 5
U54$10,191,697 · 6
U24$6,726,846 · 2
P01$2,474,081 · 2
Top collaborators
- Liang Li13 shared
- Ying Yuan13 shared
- Scott Kopetz10 shared
- Ziding Feng6 shared
- Suresh T. Chari5 shared
- Barry D. Nelkin5 shared
- Marina Pasca Di Magliano5 shared
- J. Jack Lee4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Francis M Giardiello$6,524,423
- David Sidransky$59,922,938
- Anne Marie Lennon$1,951,263
- Victor E Velculescu$5,783,536
- Mohammad Obaidul Hoque$2,723,149
Others in their field
Top investigators on “Malignant Neoplasm Of Pancreas”
- David Heimbrook · Leidos Biomedical Research, Inc.$73,277,592
- Walter John Curran · Thomas Jefferson University$26,641,549
- Surinder Kumar Batra · University Of Pittsburgh At Pittsburgh$26,074,679
- Michael A Hollingsworth · University Of Nebraska Medical Center$23,837,917
- Robert E Reiter · University Of California Los Angeles$21,473,394
- Monica M Bertagnolli · Strang Cancer Prevention Center$20,383,871
Research focus
Malignant Neoplasm Of PancreasMalignant NeoplasmsCollaborationsBaseSiteResearch PersonnelMolecularGeneticPancreasPancreatic Ductal AdenocarcinomaOperative Surgical ProceduresPathologyCancer CenterResponseInstitutionEvaluationUniversitiesTumorFundingData ManagementMonitorUnited StatesCohortDiagnosis
Grant awards (131)
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,547,663
U54 · FY2025 · CA · contact PI
Clinical Validation Center for Early Detection of Pancreatic Cancer$1,076,354
U01 · FY2025 · CA · contact PI
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)$1,010,953
U24 · FY2025 · CA · contact PI
TBEL Project 2$197,437
U54 · FY2025 · CA · contact PI
TBEL Admin Core$197,437
U54 · FY2025 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$2,164,185
U01 · FY2024 · DK
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,390,223
U54 · FY2024 · CA · contact PI
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)$972,000
U24 · FY2024 · CA · contact PI
Clinical Validation Center for Early Detection of Pancreatic Cancer$965,837
U01 · FY2024 · CA · contact PI
TBEL Admin Core$356,903
U54 · FY2024 · CA · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$322,976
U01 · FY2024 · DK
TBEL Project 2$282,471
U54 · FY2024 · CA · contact PI
Effects of Tissue Block Age on Reliability and Accuracy of In situ Transcriptomics Across Organ Sites using Xenium Technology$199,862
U54 · FY2024 · CA · contact PI
TBEL Admin Core$199,862
U54 · FY2024 · CA · contact PI
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer$2,203,749
P50 · FY2023 · CA
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,766,175
U01 · FY2023 · DK
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,600,526
U54 · FY2023 · CA · contact PI
Clinical Validation Center for Early Detection of Pancreatic Cancer$996,338
U01 · FY2023 · CA · contact PI
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)$972,000
U24 · FY2023 · CA · contact PI
TBEL Admin Core$487,467
U54 · FY2023 · CA · contact PI
TBEL Project 2$472,982
U54 · FY2023 · CA · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$350,540
U01 · FY2023 · DK
Wnt/?-catenin Signaling in Pancreatic Oncogenesis$347,918
R01 · FY2023 · CA · contact PI
Developmental Research Program$145,727
P50 · FY2023 · CA · contact PI
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer$2,211,341
P50 · FY2022 · CA
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,794,624
U01 · FY2022 · DK
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,558,076
U54 · FY2022 · CA · contact PI
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)$972,000
U24 · FY2022 · CA · contact PI
Clinical Validation Center for Early Detection of Pancreatic Cancer$737,111
U01 · FY2022 · CA · contact PI
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies$650,719
R01 · FY2022 · CA · contact PI
TBEL Project 2$391,973
U54 · FY2022 · CA · contact PI
Wnt/?-catenin Signaling in Pancreatic Oncogenesis$358,680
R01 · FY2022 · CA · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$263,224
U01 · FY2022 · DK
Developmental Research Program$152,719
P50 · FY2022 · CA · contact PI
TBEL Admin Core$151,713
U54 · FY2022 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$2,323,998
U01 · FY2021 · DK
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer$1,987,442
P50 · FY2021 · CA
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies$663,998
R01 · FY2021 · CA · contact PI
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer$595,717
R01 · FY2021 · CA · contact PI
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)$559,976
U24 · FY2021 · CA · contact PI
A Clinical Validation Center for Early Detection of Pancreatic Cancer$532,530
U01 · FY2021 · CA · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$453,329
U01 · FY2021 · DK
Wnt/?-catenin Signaling in Pancreatic Oncogenesis$366,000
R01 · FY2021 · CA · contact PI
Developmental Research Program$248,430
P50 · FY2021 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$2,339,500
U01 · FY2020 · DK
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer$2,309,154
P50 · FY2020 · CA
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$2,000,000
U01 · FY2020 · DK
A Clinical Validation Center for Early Detection of Pancreatic Cancer$752,866
U01 · FY2020 · CA · contact PI
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas$674,985
U01 · FY2020 · CA · contact PI
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies$663,998
R01 · FY2020 · CA · contact PI
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer$597,598
R01 · FY2020 · CA · contact PI
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)$559,976
U24 · FY2020 · CA · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$468,829
U01 · FY2020 · DK
Wnt/?-catenin Signaling in Pancreatic Oncogenesis$366,000
R01 · FY2020 · CA · contact PI
Core A: Pathology Core$226,306
P01 · FY2020 · CA · contact PI
Developmental Research Program$151,998
P50 · FY2020 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$2,873,279
U01 · FY2019 · DK
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer$2,275,719
P50 · FY2019 · CA
A Clinical Validation Center for Early Detection of Pancreatic Cancer$1,486,995
U01 · FY2019 · CA · contact PI
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas$1,223,879
U01 · FY2019 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$706,028
U01 · FY2019 · DK
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies$644,078
R01 · FY2019 · CA · contact PI
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer$579,669
R01 · FY2019 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$485,856
U01 · FY2019 · DK
Core A: Pathology Core$222,898
P01 · FY2019 · CA · contact PI
Developmental Research Program$148,800
P50 · FY2019 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$72,695
U01 · FY2019 · DK
Wnt/?-catenin Signaling in Pancreatic Oncogenesis$1
R01 · FY2019 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$2,917,324
U01 · FY2018 · DK
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas$1,107,123
U01 · FY2018 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,000,000
U01 · FY2018 · DK
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,000,000
U01 · FY2018 · DK
A Clinical Validation Center for Early Detection of Pancreatic Cancer$760,296
U01 · FY2018 · CA · contact PI
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies$663,998
R01 · FY2018 · CA · contact PI
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer$597,598
R01 · FY2018 · CA · contact PI
Core A: Pathology Core$230,629
P01 · FY2018 · CA · contact PI
A Clinical Validation Center for Early Detection of Pancreatic Cancer$1,759,344
U01 · FY2017 · CA · contact PI
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)$1,679,941
U24 · FY2017 · CA
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,552,014
U01 · FY2017 · DK
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,500,000
U01 · FY2017 · DK
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas$787,123
U01 · FY2017 · CA · contact PI
Wnt/?-catenin Signaling in Pancreatic Oncogenesis$366,000
R01 · FY2017 · CA · contact PI
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas$320,000
U01 · FY2017 · CA · contact PI
Core A: Pathology Core$89,149
P01 · FY2017 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,531,648
U01 · FY2016 · DK
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,000,000
U01 · FY2016 · DK
A Clinical Validation Center for Early Detection of Pancreatic Cancer$794,418
U01 · FY2016 · CA · contact PI
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas$787,123
U01 · FY2016 · CA · contact PI
A Clinical Validation Center for Early Detection of Pancreatic Cancer$254,464
U01 · FY2016 · CA · contact PI
Targeting Kras in Pancreatic Cancer$208,800
R21 · FY2016 · CA
Core A: Pathology Core$193,000
P01 · FY2016 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$1,582,014
U01 · FY2015 · DK
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas$860,394
U01 · FY2015 · CA · contact PI
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)$201,348
U01 · FY2015 · DK
Targeting Kras in Pancreatic Cancer$174,000
R21 · FY2015 · CA
Developmental Signaling Pathways in Pancreatic Cancer$290,374
R01 · FY2014 · CA · contact PI
Systemic Nanocurcumin for Pancreatic Cancer Therapy$177,588
U54 · FY2014 · CA · contact PI
The Hippo Signaling Pathway in Pancreatic Cancer$334,090
P01 · FY2013 · CA · contact PI
Developmental Signaling Pathways in Pancreatic Cancer$288,428
R01 · FY2013 · CA · contact PI
Systemic Nanocurcumin for Pancreatic Cancer Therapy$284,683
U54 · FY2013 · CA · contact PI
The Johns Hopkins Cancer Nanotechnology Training Center$346,312
R25 · FY2012 · CA
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development$330,091
R01 · FY2012 · CA
Developmental Signaling Pathways in Pancreatic Cancer$306,839
R01 · FY2012 · CA · contact PI
The Hippo Signaling Pathway in Pancreatic Cancer$293,520
P01 · FY2012 · CA · contact PI
Systemic Nanocurcumin for Pancreatic Cancer Therapy$277,188
U54 · FY2012 · CA · contact PI
The Johns Hopkins Cancer Nanotechnology Training Center$349,499
R25 · FY2011 · CA
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development$330,091
R01 · FY2011 · CA
Developmental Signaling Pathways in Pancreatic Cancer$306,839
R01 · FY2011 · CA · contact PI
The Hippo Signaling Pathway in Pancreatic Cancer$292,771
P01 · FY2011 · CA · contact PI
Fundamentals of Early and Variant Pancreatic Neoplasia$202,962
P50 · FY2011 · CA · contact PI
Systemic Nanocurcumin for Pancreatic Cancer Therapy$202,472
U54 · FY2011 · CA · contact PI
The Johns Hopkins Cancer Nanotechnology Training Center$368,155
R25 · FY2010 · CA
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development$340,300
R01 · FY2010 · CA
Developmental Signaling Pathways in Pancreatic Cancer$316,328
R01 · FY2010 · CA · contact PI
The Hippo Signaling Pathway in Pancreatic Cancer$300,518
P01 · FY2010 · CA · contact PI
Systemic Nanocurcumin for Pancreatic Cancer Therapy$215,171
U54 · FY2010 · CA · contact PI
Fundamentals of Early and Variant Pancreatic Neoplasia$213,897
P50 · FY2010 · CA · contact PI
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development$340,300
R01 · FY2009 · CA
Hedgehog Inhibitors in Pancreas Cancer$307,115
R01 · FY2009 · CA · contact PI
The Hippo Signaling Pathway in Pancreatic Cancer$291,200
P01 · FY2009 · CA · contact PI
Fundamentals of Early and Variant Pancreatic Neoplasia$214,276
P50 · FY2009 · CA · contact PI
Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development$340,300
R01 · FY2008 · CA
Hedgehog Inhibitors in Pancreas Cancer$307,115
R01 · FY2008 · CA · contact PI
Fundamentals of Early and Variant Pancreatic Neoplasia$213,955
P50 · FY2008 · CA · contact PI
Hedgehog Inhibitors in Pancreas Cancer$306,881
R01 · FY2007 · CA · contact PI
Fundamentals of Early and Variant Pancreatic Neoplasia$208,732
P50 · FY2007 · CA · contact PI
Hedgehog Inhibitors in Pancreas Cancer$315,082
R01 · FY2006 · CA · contact PI
Hedgehog signaling in pancreatic neoplasia$239,548
R21 · FY2006 · DK · contact PI
Hedgehog Inhibitors in Pancreas Cancer$321,185
R01 · FY2005 · CA
Hedgehog signaling in pancreatic neoplasia$203,802
R21 · FY2005 · DK
A Sequencing Microarray for Mitochondrial Mutations$147,101
R21 · FY2004 · CA